Drug shortage: Midazolam Hydrochloride Injection (MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE)
FDA lists 27 presentations as Current. Availability: Unavailable (8), Limited Availability (3), Available (16). Reason: Demand increase for the drug; Other. Companies: Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Avet Pharmaceuticals, Inc., Gland Pharma Limited, Fresenius Kabi USA, LLC….
- Published by source
- 2020-04-02
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-23
Affected
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Products
- Midazolam Hydrochloride Injection MIDAZOLAM MIDAZOLAM HYDROCHLORIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027
- Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: March 2027
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-04-02
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #847 | new | 2026-10-22 | 1cb08581ee43…c6a318 | 636d2007b835…531607 |
| #1144 | update | 2026-10-23 | d3504900aae6…411622 | 33eae9d8e4ab…a6e154 |
Chain head: #1250 0c9a4a81d7d8…29590d